Targeting mucosal-associated invariant T cells using riboflavin metabolism derived TCR ligands for innate immunotherapy of liver cancer - Betz, J-P; Krpicak, T J; Huang, P; Ma, C; Trehan, R; Kurkunov, M; Gehringer, M; Beyer, S; Garcia Rollmann, E; Yang, Y-P; Wistuba-Hamprecht, K; Malek, N P; Greten, T F; Korangy, F; Ruf, B (Zeitschrift für Gastroenterologie, 2025)